Financhill
Back

4D Molecular Therapeutics, Inc. Stock Price Chart

  • The current trend is moderately bearish and FDMT is experiencing selling pressure, which indicates risk of future bearish movement.

4D Molecular Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 10.82 Sell
20-day SMA: 10.7 Buy
50-day SMA: 10.32 Buy
200-day SMA: 6 Buy
8-day EMA: 10.78 Sell
20-day EMA: 10.73 Sell
50-day EMA: 10.03 Buy
200-day EMA: 8.04 Buy

4D Molecular Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.13 Buy
Relative Strength Index (14 RSI): 50.62 Buy
Chaikin Money Flow: -450556 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.37 - 11.15) Sell
Bollinger Bands (100): (5.95 - 10.57) Buy

4D Molecular Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for 4D Molecular Therapeutics, Inc. Stock

Is 4D Molecular Therapeutics, Inc. Stock a Buy?

FDMT Technical Analysis vs Fundamental Analysis

Sell
42
4D Molecular Therapeutics, Inc. (FDMT) is a Sell

Is 4D Molecular Therapeutics, Inc. a Buy or a Sell?

4D Molecular Therapeutics, Inc. Stock Info

Market Cap:
611.3M
Price in USD:
10.70
Share Volume:
485.7K

4D Molecular Therapeutics, Inc. 52-Week Range

52-Week High:
12.34
52-Week Low:
2.24
Sell
42
4D Molecular Therapeutics, Inc. (FDMT) is a Sell

4D Molecular Therapeutics, Inc. Share Price Forecast

Is 4D Molecular Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of 4D Molecular Therapeutics, Inc.

Is 4D Molecular Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.33 per share, and a decrease next year of $0.22 per share.

Technical Analysis of 4D Molecular Therapeutics, Inc.

Should I short 4D Molecular Therapeutics, Inc. stock?

* 4D Molecular Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.